308 related articles for article (PubMed ID: 8974008)
1. In vitro comparison of inhibiting ability of soluble TNF receptor p75 (TBP II) vs. soluble TNF receptor p55 (TBP I) against TNF-alpha and TNF-beta.
Terlizzese M; Simoni P; Antonetti F
J Interferon Cytokine Res; 1996 Dec; 16(12):1047-53. PubMed ID: 8974008
[TBL] [Abstract][Full Text] [Related]
2. Minimal tumor necrosis factor receptor binding protein: optimum biological activity of a truncated p55 soluble tumor necrosis factor receptor-IgG fusion protein.
Corcoran AE; Scallon BJ; Trinh H; Chernajovsky Y; Ghrayeb J; Feldmann M
Eur Cytokine Netw; 1998 Sep; 9(3):255-62. PubMed ID: 9831174
[TBL] [Abstract][Full Text] [Related]
3. The tumour necrosis factor family of receptors/ligands in the serum of patients with rheumatoid arthritis.
Robak T; Gladalska A; Stepień H
Eur Cytokine Netw; 1998 Jun; 9(2):145-54. PubMed ID: 9681390
[TBL] [Abstract][Full Text] [Related]
4. TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation.
Peschon JJ; Torrance DS; Stocking KL; Glaccum MB; Otten C; Willis CR; Charrier K; Morrissey PJ; Ware CB; Mohler KM
J Immunol; 1998 Jan; 160(2):943-52. PubMed ID: 9551933
[TBL] [Abstract][Full Text] [Related]
5. Characterization of ligand binding by the human p55 tumour-necrosis-factor receptor. Involvement of individual cysteine-rich repeats.
Corcoran AE; Barrett K; Turner M; Brown A; Kissonerghis AM; Gadnell M; Gray PW; Chernajovsky Y; Feldmann M
Eur J Biochem; 1994 Aug; 223(3):831-40. PubMed ID: 8055960
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor (TNF)-induced cutaneous necrosis is mediated by TNF receptor 1.
Amar S; Van Dyke TE; Eugster HP; Schultze N; Koebel P; Bluethmann H
J Inflamm; 1995-1996; 47(4):180-9. PubMed ID: 9144075
[TBL] [Abstract][Full Text] [Related]
7. A murine transmembrane tumor necrosis factor (TNF) transgene induces arthritis by cooperative p55/p75 TNF receptor signaling.
Alexopoulou L; Pasparakis M; Kollias G
Eur J Immunol; 1997 Oct; 27(10):2588-92. PubMed ID: 9368614
[TBL] [Abstract][Full Text] [Related]
8. The role of the two TNF receptors in proliferation, NF-kappa B activation and discrimination between TNF and LT alpha signalling in the human myeloma cell line OH-2.
Börset M; Medvedev AE; Sundan A; Espevik T
Cytokine; 1996 Jun; 8(6):430-8. PubMed ID: 8818539
[TBL] [Abstract][Full Text] [Related]
9. Crucial role of tumor necrosis factor (TNF) receptor 2 and membrane-bound TNF in experimental cerebral malaria.
Lucas R; Juillard P; Decoster E; Redard M; Burger D; Donati Y; Giroud C; Monso-Hinard C; De Kesel T; Buurman WA; Moore MW; Dayer JM; Fiers W; Bluethmann H; Grau GE
Eur J Immunol; 1997 Jul; 27(7):1719-25. PubMed ID: 9247583
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75.
Sheehan KC; Pinckard JK; Arthur CD; Dehner LP; Goeddel DV; Schreiber RD
J Exp Med; 1995 Feb; 181(2):607-17. PubMed ID: 7836916
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-alpha-induced skin inflammation.
Kondo S; Sauder DN
Eur J Immunol; 1997 Jul; 27(7):1713-8. PubMed ID: 9247582
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
Mackay F; Bourdon PR; Griffiths DA; Lawton P; Zafari M; Sizing ID; Miatkowski K; Ngam-ek A; Benjamin CD; Hession C; Ambrose CM; Meier W; Browning JL
J Immunol; 1997 Oct; 159(7):3299-310. PubMed ID: 9317128
[TBL] [Abstract][Full Text] [Related]
13. IL-2-induced tumor necrosis factor (TNF)-beta expression: further analysis in the IL-2 knockout model, and comparison with TNF-alpha, lymphotoxin-beta, TNFR1 and TNFR2 modulation.
Reddy J; Chastagner P; Fiette L; Liu X; Thèze J
Int Immunol; 2001 Feb; 13(2):135-47. PubMed ID: 11157847
[TBL] [Abstract][Full Text] [Related]
14. Membrane lymphotoxin is required for resistance to Theiler's virus infection.
Lin X; Ma X; Rodriguez M; Feng X; Zoecklein L; Fu YX; Roos RP
Int Immunol; 2003 Aug; 15(8):955-62. PubMed ID: 12882833
[TBL] [Abstract][Full Text] [Related]
15. Dual role of the p75 tumor necrosis factor (TNF) receptor in TNF cytotoxicity.
Bigda J; Beletsky I; Brakebusch C; Varfolomeev Y; Engelmann H; Bigda J; Holtmann H; Wallach D
J Exp Med; 1994 Aug; 180(2):445-60. PubMed ID: 7519237
[TBL] [Abstract][Full Text] [Related]
16. Soluble tumor necrosis factor (TNF) receptors p55 and p75 and interleukin-10 downregulate TNF-alpha activity during the lung response to silica particles in NMRI mice.
Huaux F; Arras M; Vink A; Renauld JC; Lison D
Am J Respir Cell Mol Biol; 1999 Jul; 21(1):137-45. PubMed ID: 10385602
[TBL] [Abstract][Full Text] [Related]
17. Activation of the TNF alpha-p55 receptor induces myocyte proliferation and modulates agonist-evoked calcium transients in cultured human tracheal smooth muscle cells.
Amrani Y; Panettieri RA; Frossard N; Bronner C
Am J Respir Cell Mol Biol; 1996 Jul; 15(1):55-63. PubMed ID: 8679222
[TBL] [Abstract][Full Text] [Related]
18. Autocrine tumor necrosis factor (TNF) and lymphotoxin (LT) alpha differentially modulate cellular sensitivity to TNF/LT-alpha cytotoxicity in L929 cells.
Decoster E; Cornelis S; Vanhaesebroeck B; Fiers W
J Cell Biol; 1998 Dec; 143(7):2057-65. PubMed ID: 9864375
[TBL] [Abstract][Full Text] [Related]
19. Obesity and diabetes in TNF-alpha receptor- deficient mice.
Schreyer SA; Chua SC; LeBoeuf RC
J Clin Invest; 1998 Jul; 102(2):402-11. PubMed ID: 9664082
[TBL] [Abstract][Full Text] [Related]
20. Functional comparisons of different tumour necrosis factor receptor/IgG fusion proteins.
Scallon BJ; Trinh H; Nedelman M; Brennan FM; Feldmann M; Ghrayeb J
Cytokine; 1995 Nov; 7(8):759-70. PubMed ID: 8664442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
